HealthCare Royalty Announces Royalty Monetization Agreement for Modeyso® Commercial Royalties
KKR & Co. Inc. (KKR)
Last kkr & co. inc. earnings: 1/31 06:50 am
Check Earnings Report
US:NYSE Investor Relations:
ir.kkr.com
Company Research
Source: Business Wire
STAMFORD, Conn.--(BUSINESS WIRE)--HealthCare Royalty (“HCRx”) today announced it has entered into a royalty monetization agreement with the Advisory Group representing the former Oncoceutics Inc. securityholders for an undisclosed percentage of royalties on Modeyso® (dordaviprone) commercial sales.Modeyso received U.S. FDA accelerated approval in August 2025 for the treatment of adult and pediatric patients 1 year of age and older with diffuse midline glioma harboring an H3 K27M mutation with progressive disease following prior therapy. Modeyso is commercialized by Jazz Pharmaceuticals.“Since its launch in August, Modeyso has demonstrated strong early performance, reflecting the significant unmet need, high awareness driven by advocacy groups, and the value physicians see for patients with H3 K27M-mutant diffuse midline glioma,” said Clarke Futch, Chairman and Chief Executive Officer of HealthCare Royalty. “We believe Modeyso is uniquely positioned to bring meaningful benefit to p
Show less
Read more
Impact Snapshot
Event Time:
KKR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KKR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KKR alerts
High impacting KKR & Co. Inc. news events
Weekly update
A roundup of the hottest topics
KKR
News
- Vertical Bridge Announces $1.5 billion Strategic Equity Investment from KKRBusiness Wire
- KKR & Co. Inc. (KKR) had its price target lowered by Morgan Stanley from $177.00 to $153.00. They now have an "overweight" rating on the stock.MarketBeat
- KIO: High Beta Fixed Income CEF With Significant Downside (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- KKR & Co. Inc. (KKR) was downgraded by Zacks Research from "hold" to "strong sell".MarketBeat
- KKR and Samsung SDS Form Strategic Partnership to Drive Long-Term Value CreationBusiness Wire
KKR
Earnings
- 2/5/26 - Beat
KKR
Sec Filings
- 3/13/26 - Form DEFA14A
- 3/5/26 - Form 4
- 3/3/26 - Form 4
- KKR's page on the SEC website